SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Lehto J)
 

Search: WFRF:(Lehto J) > PFKFB3 Inhibition S...

  • Ninou, AH (author)

PFKFB3 Inhibition Sensitizes DNA Crosslinking Chemotherapies by Suppressing Fanconi Anemia Repair

  • Article/chapterEnglish2021

Publisher, publication year, extent ...

  • 2021-07-18
  • MDPI AG,2021

Numbers

  • LIBRIS-ID:oai:prod.swepub.kib.ki.se:147131054
  • http://kipublications.ki.se/Default.aspx?queryparsed=id:147131054URI
  • https://doi.org/10.3390/cancers13143604DOI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • Replicative repair of interstrand crosslinks (ICL) generated by platinum chemotherapeutics is orchestrated by the Fanconi anemia (FA) repair pathway to ensure resolution of stalled replication forks and the maintenance of genomic integrity. Here, we identify novel regulation of FA repair by the cancer-associated glycolytic enzyme PFKFB3 that has functional consequences for replication-associated ICL repair and cancer cell survival. Inhibition of PFKFB3 displays a cancer-specific synergy with platinum compounds in blocking cell viability and restores sensitivity in treatment-resistant models. Notably, the synergies are associated with DNA-damage-induced chromatin association of PFKFB3 upon cancer transformation, which further increases upon platinum resistance. FA pathway activation triggers the PFKFB3 assembly into nuclear foci in an ATR- and FANCM-dependent manner. Blocking PFKFB3 activity disrupts the assembly of key FA repair factors and consequently prevents fork restart. This results in an incapacity to replicate cells to progress through S-phase, an accumulation of DNA damage in replicating cells, and fork collapse. We further validate PFKFB3-dependent regulation of FA repair in ex vivo cultures from cancer patients. Collectively, targeting PFKFB3 opens up therapeutic possibilities to improve the efficacy of ICL-inducing cancer treatments.

Added entries (persons, corporate bodies, meetings, titles ...)

  • Lehto, J (author)
  • Chioureas, D (author)
  • Stigsdotter, HKarolinska Institutet (author)
  • Schelzig, K (author)
  • Akerlund, E (author)
  • Gudoityte, GKarolinska Institutet (author)
  • Joneborg, UKarolinska Institutet (author)
  • Carlson, J (author)
  • Jonkers, J (author)
  • Seashore-Ludlow, BKarolinska Institutet (author)
  • Gustafsson, NMS (author)
  • Karolinska Institutet (creator_code:org_t)

Related titles

  • In:Cancers: MDPI AG13:142072-6694

Internet link

Find in a library

  • Cancers (Search for host publication in LIBRIS)

To the university's database

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view